vs
Side-by-side financial comparison of BRAND HOUSE COLLECTIVE, INC. (TBHC) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
BRAND HOUSE COLLECTIVE, INC. is the larger business by last-quarter revenue ($103.5M vs $70.6M, roughly 1.5× Viridian Therapeutics, Inc.\DE). BRAND HOUSE COLLECTIVE, INC. runs the higher net margin — -3.6% vs -49.0%, a 45.4% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -9.6%). BRAND HOUSE COLLECTIVE, INC. produced more free cash flow last quarter ($-26.8M vs $-84.7M).
Soho House is an international private members’ club with a focus on the media, arts and fashion industries.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
TBHC vs VRDN — Head-to-Head
Income Statement — Q3 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $103.5M | $70.6M |
| Net Profit | $-3.7M | $-34.6M |
| Gross Margin | 20.4% | — |
| Operating Margin | -1.9% | -56.7% |
| Net Margin | -3.6% | -49.0% |
| Revenue YoY | -9.6% | 81958.1% |
| Net Profit YoY | 51.8% | 54.9% |
| EPS (diluted) | $-0.16 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $103.5M | — | ||
| Q3 25 | $75.8M | $70.6M | ||
| Q2 25 | $81.5M | — | ||
| Q1 25 | $148.9M | — | ||
| Q4 24 | $114.4M | — | ||
| Q3 24 | $86.3M | — | ||
| Q2 24 | $91.8M | — | ||
| Q1 24 | $165.9M | — |
| Q4 25 | $-3.7M | — | ||
| Q3 25 | $-20.2M | $-34.6M | ||
| Q2 25 | $-11.8M | — | ||
| Q1 25 | $7.9M | — | ||
| Q4 24 | $-7.7M | — | ||
| Q3 24 | $-14.5M | — | ||
| Q2 24 | $-8.8M | — | ||
| Q1 24 | $10.1M | — |
| Q4 25 | 20.4% | — | ||
| Q3 25 | 16.3% | — | ||
| Q2 25 | 24.9% | — | ||
| Q1 25 | 30.3% | — | ||
| Q4 24 | 28.1% | — | ||
| Q3 24 | 20.5% | — | ||
| Q2 24 | 29.5% | — | ||
| Q1 24 | 32.0% | — |
| Q4 25 | -1.9% | — | ||
| Q3 25 | -24.7% | -56.7% | ||
| Q2 25 | -12.9% | — | ||
| Q1 25 | 6.2% | — | ||
| Q4 24 | -2.1% | — | ||
| Q3 24 | -15.4% | — | ||
| Q2 24 | -8.2% | — | ||
| Q1 24 | 6.4% | — |
| Q4 25 | -3.6% | — | ||
| Q3 25 | -26.6% | -49.0% | ||
| Q2 25 | -14.5% | — | ||
| Q1 25 | 5.3% | — | ||
| Q4 24 | -6.7% | — | ||
| Q3 24 | -16.8% | — | ||
| Q2 24 | -9.6% | — | ||
| Q1 24 | 6.1% | — |
| Q4 25 | $-0.16 | — | ||
| Q3 25 | $-0.90 | — | ||
| Q2 25 | $-0.54 | — | ||
| Q1 25 | $0.61 | — | ||
| Q4 24 | $-0.59 | — | ||
| Q3 24 | $-1.11 | — | ||
| Q2 24 | $-0.68 | — | ||
| Q1 24 | $0.80 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.5M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-44.0M | $503.0M |
| Total Assets | $229.2M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.5M | — | ||
| Q3 25 | $3.6M | $490.9M | ||
| Q2 25 | $3.5M | — | ||
| Q1 25 | $3.8M | — | ||
| Q4 24 | $6.8M | — | ||
| Q3 24 | $4.5M | — | ||
| Q2 24 | $3.8M | — | ||
| Q1 24 | $3.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $64.0M | — | ||
| Q4 24 | $85.8M | — | ||
| Q3 24 | $61.4M | — | ||
| Q2 24 | $47.5M | — | ||
| Q1 24 | $34.0M | — |
| Q4 25 | $-44.0M | — | ||
| Q3 25 | $-35.2M | $503.0M | ||
| Q2 25 | $-16.2M | — | ||
| Q1 25 | $-19.0M | — | ||
| Q4 24 | $-27.1M | — | ||
| Q3 24 | $-19.7M | — | ||
| Q2 24 | $-5.5M | — | ||
| Q1 24 | $3.1M | — |
| Q4 25 | $229.2M | — | ||
| Q3 25 | $221.9M | $577.1M | ||
| Q2 25 | $225.4M | — | ||
| Q1 25 | $242.2M | — | ||
| Q4 24 | $279.8M | — | ||
| Q3 24 | $266.2M | — | ||
| Q2 24 | $242.6M | — | ||
| Q1 24 | $250.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.88× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.9M | $-84.6M |
| Free Cash FlowOCF − Capex | $-26.8M | $-84.7M |
| FCF MarginFCF / Revenue | -25.9% | -120.1% |
| Capex IntensityCapex / Revenue | 0.9% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-18.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.9M | — | ||
| Q3 25 | $-7.0M | $-84.6M | ||
| Q2 25 | $-3.1M | — | ||
| Q1 25 | $19.8M | — | ||
| Q4 24 | $-12.6M | — | ||
| Q3 24 | $-12.7M | — | ||
| Q2 24 | $-13.7M | — | ||
| Q1 24 | $28.2M | — |
| Q4 25 | $-26.8M | — | ||
| Q3 25 | $-7.4M | $-84.7M | ||
| Q2 25 | $-3.6M | — | ||
| Q1 25 | $19.0M | — | ||
| Q4 24 | $-13.1M | — | ||
| Q3 24 | $-13.2M | — | ||
| Q2 24 | $-14.4M | — | ||
| Q1 24 | $26.7M | — |
| Q4 25 | -25.9% | — | ||
| Q3 25 | -9.8% | -120.1% | ||
| Q2 25 | -4.5% | — | ||
| Q1 25 | 12.8% | — | ||
| Q4 24 | -11.5% | — | ||
| Q3 24 | -15.2% | — | ||
| Q2 24 | -15.7% | — | ||
| Q1 24 | 16.1% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.6% | 0.2% | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.51× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.79× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
